Last 5th and 6th of December 2016 was celebrated The Workshop on Measuring the Impact of Pharmacovigilance Activities in London, organized by the European Medicine Agency.
In January 2016 PRAC adopted a strategy for measuring the impact of pharmacovigilance activities. This relies on the collaboration between stakeholders to assess whether pharmacovigilance systems are fully achieving their public health objectives, and to identify areas for improvement.
The workshop’s objective was to develop methods in impact research and to identify enablers and barriers to measuring the impact of pharmacovigilance. Particular focus on new methods for measuring the impact of product-specific pharmacovigilance activities on clinical practice and health outcomes, as well as the impact of individual pharmacovigilance processes.
This event was an excellent opportunity to bring together the available expertise from partners and stakeholders, including:
Regulatory Bodies
EU and national regulatory agencies
International regulatory bodies
Public Bodies
National Healthauthorities
The European Commission
The WHO
Academia and learned Societies
Healthcare Professional Organisations
Patient and Consumer Organisations
Pharmaceutical Industry Associations
If you want a complete information about the Workshop, please click on EVENT PRESENTATIONS
Also if you want to see the video available of the workshop, please click on WORKSHOP VIDEO
